Sharechat Logo

NZ Aluminium Smelters halts $70M of capital spending

Monday 29th October 2012

Text too small?

New Zealand Aluminium Smelters, which operates the plant at Bluff, has halted $70 million of planned capital spending, citing "extremely challenging" market conditions that have eroded margins.

The change affects $15 million planned for the remainder of 2012 and 2013 and follows a review of all capital and maintenance spending at the site, it said in a statement.

"Given the extremely challenging market conditions, halting project work on site is one of a number of actions being taken to try and return NZAS to viability as quickly as possible," said general manager Ryan Cavanagh.

"Other initiatives include the completion of an organizational restructure, including implementing redundancies, by the end of November," he said.

NZAS is in talks over electricity prices for the aluminium smelter with Meridian Energy as the operation that takes about 15 percent of New Zealand's electricity seeks to trim one of its biggest expenses.

This month the company said it will eliminate 65 of its 800 workers in addition to 100 to be shed over five years that it flagged last year.

Rio Tinto owns 79.36 percent of NZAS and Sumitomo Chemical owns the remaining shares.

BusinessDesk.co.nz



  General Finance Advertising    

Comments from our readers

No comments yet

Add your comment:
Your name:
Your email:
Not displayed to the public
Comment:
Comments to Sharechat go through an approval process. Comments which are defamatory, abusive or in some way deemed inappropriate will not be approved. It is allowable to use some form of non-de-plume for your name, however we recommend real email addresses are used. Comments from free email addresses such as Gmail, Yahoo, Hotmail, etc may not be approved.

Related News:

December 27th Morning Report
FBU - Fletcher Building Announces Director Appointment
December 23rd Morning Report
MWE - Suspension of Trading and Delisting
EBOS welcomes finalisation of First PWA
CVT - AMENDED: Bank covenant waiver and trading update
Gentrack Annual Report 2024
December 20th Morning Report
Rua Bioscience announces launch of new products in the UK
TEM - Appointment to the Board of Directors